Kura Oncology (KURA) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free KURA Stock Alerts $19.65 +0.65 (+3.42%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKura Oncology (KURA) Scheduled to Post Quarterly Earnings on Thursdaymarketbeat.com - April 26 at 11:03 AMKura Oncology to Report First Quarter 2024 Financial Resultsglobenewswire.com - April 25 at 7:30 AMFDA grants breakthrough status for Kura Oncology's AML drug candicateuk.investing.com - April 24 at 9:38 PMKura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 24 at 2:48 AMKura Oncology (NASDAQ:KURA) Given "Buy" Rating at HC Wainwrightamericanbankingnews.com - April 23 at 3:34 AMKura Oncology, Inc.: Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AMLfinanznachrichten.de - April 23 at 1:50 AMKura Oncology’s Buy Rating Affirmed by Analyst Joseph Pantginis Amid Breakthrough Therapy Designation and Promising Preclinical Datamarkets.businessinsider.com - April 22 at 3:48 PMKura Oncology (NASDAQ:KURA) Rating Reiterated by HC Wainwrightmarketbeat.com - April 22 at 2:24 PMKura Oncology (NASDAQ:KURA) Shares Gap Up to $17.53marketbeat.com - April 22 at 12:49 PMKura Oncology Gets FDA Breakthrough Therapy Designation For Ziftomenib In R/R NPM1-Mutant AMLmarkets.businessinsider.com - April 22 at 10:43 AMKura Oncology Gets Breakthrough Designation For Leukemia Therapymarketwatch.com - April 22 at 10:43 AMKura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AMLfinance.yahoo.com - April 22 at 10:43 AMStockNews.com Downgrades Kura Oncology (NASDAQ:KURA) to Sellmarketbeat.com - April 15 at 11:09 PMDekaBank Deutsche Girozentrale Buys 65,000 Shares of Kura Oncology, Inc. (NASDAQ:KURA)marketbeat.com - April 15 at 5:09 AMVanguard Group Inc. Increases Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)marketbeat.com - April 11 at 4:11 AMImmunotherapy After Definitive Therapy Flops in Head and Neck Cancermsn.com - April 10 at 7:27 PMValidea Detailed Fundamental Analysis - KURAnasdaq.com - April 10 at 9:26 AMKura Oncology to Participate in Stifel Targeted Oncology Forumglobenewswire.com - April 10 at 7:30 AMKura Oncology to Participate in Stifel Targeted Oncology Forumglobenewswire.com - April 10 at 7:30 AMKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 5 at 7:30 AMKura Oncology (NASDAQ:KURA) Upgraded to "Hold" by StockNews.commarketbeat.com - April 3 at 11:11 PMStifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC)markets.businessinsider.com - March 28 at 3:11 PMKura Oncology (NASDAQ:KURA) Shares Gap Down to $21.69marketbeat.com - March 20 at 12:45 PMWalleye Capital LLC Buys 182,221 Shares of Kura Oncology, Inc. (NASDAQ:KURA)marketbeat.com - March 17 at 4:20 AMTrexquant Investment LP Reduces Stake in Kura Oncology, Inc. (NASDAQ:KURA)marketbeat.com - March 12 at 4:22 AMKura Oncology (NASDAQ:KURA) Hits New 1-Year High at $23.75marketbeat.com - March 7 at 10:51 AMBuy Rating Affirmed: Kura Oncology’s KO-2806 Shows Promising Clinical and Market Potentialmarkets.businessinsider.com - March 7 at 12:05 AMKura Oncology, Inc.: Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinomafinanznachrichten.de - March 6 at 7:05 PMKura Oncology (NASDAQ:KURA) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - March 6 at 12:42 PMKura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinomaglobenewswire.com - March 6 at 7:30 AMCharles Schwab Investment Management Inc. Has $5.14 Million Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)marketbeat.com - March 5 at 4:33 AMKura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Rating of "Moderate Buy" from Brokeragesmarketbeat.com - March 5 at 1:33 AMKura Oncology, Inc. Forecasted to Earn Q1 2024 Earnings of ($0.58) Per Share (NASDAQ:KURA)marketbeat.com - March 2 at 2:28 AMKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 1 at 5:00 PMBuy Rating for Kura Oncology Amid Strong Q4 Results and Promising Ziftomenib Trialsmarkets.businessinsider.com - March 1 at 3:31 PMFY2026 EPS Estimates for Kura Oncology, Inc. (NASDAQ:KURA) Decreased by Brookline Capital Managementmarketbeat.com - March 1 at 8:45 AMHC Wainwright Comments on Kura Oncology, Inc.'s Q1 2024 Earnings (NASDAQ:KURA)marketbeat.com - February 29 at 7:57 AMKura Oncology’s Ziftomenib Shows Promising Clinical Progress with Strong Market Potential and Buy Ratingmarkets.businessinsider.com - February 28 at 8:55 PMKURA Jul 2024 22.500 callfinance.yahoo.com - February 28 at 3:55 PMBuy Rating for Kura Oncology: Promising Pipeline and Strategic Advantages Solidify Market Positionmarkets.businessinsider.com - February 28 at 3:55 PMStrong Buy Rating for Kura Oncology Based on Solid Financials and Promising Clinical Trialsmarkets.businessinsider.com - February 28 at 3:55 PMTD Cowen Sticks to Its Buy Rating for Kura Oncology (KURA)markets.businessinsider.com - February 28 at 8:07 AMQ4 2023 Kura Oncology Inc Earnings Callfinance.yahoo.com - February 28 at 8:07 AMKura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 27 at 8:36 PMKura Oncology Inc (KURA) Reports Q4 and Full Year 2023 Financial Resultsfinance.yahoo.com - February 27 at 8:27 PMKura Oncology Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - February 27 at 4:01 PMKura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemiaglobenewswire.com - February 26 at 7:30 AMDark Forest Capital Management LP Acquires New Position in Kura Oncology, Inc. (NASDAQ:KURA)marketbeat.com - February 26 at 6:30 AMKura Oncology (KURA) Price Target Increased by 6.63% to 30.77msn.com - February 25 at 8:11 AMKura Oncology to Participate in Three Upcoming Investor Conferencesfinance.yahoo.com - February 22 at 10:25 AM Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 KURA Media Mentions By Week KURA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼0.590.32▲Average Medical News Sentiment KURA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼134▲KURA Articles Average Week Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MORF News RCUS News AKRO News DAWN News EWTX News ANIP News ARDX News GYRE News ZLAB News DVAX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
